883
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Dermal absorption of cyclic and linear siloxanes: a review

, &

References

  • Barba, C., C. Alonso, M. Martí, A. Manich, and L. Coderch. 2016. “Skin Barrier Modification with Organic Solvents.” Biochimica Biophysica Acta 1858 (8): 1935–1943. https://doi.org/10.1016/j.bbamem.2016.05.009.
  • Biesterbos, J. W., G. Beckmann, L. van Wel, R. B. Anzion, N. von Goetz, T. Dudzina, N. Roeleveld, A. M. Ragas, F. G. Russel, and P. T. Scheepers. 2015. “Aggregate dermal exposure to cyclic siloxanes in personal care products: implications for risk assessment.” Environment International 74:231–239. https://doi.org/10.1016/j.envint.2014.10.017.
  • Charles, J., and H. Destaillats 2005. Experimental Determinations of Henry’s Law Constants of Polybrominated Diphenyl Ethers (PCDEs) to Evaluate Exposure to Aquatic Biota. UC Berkeley Technical Completion Reports. Accessed January 26, 2024. https://escholarship.org/uc/item/9zv0s4np.
  • Danish Environmental Protection Agency. 2021. “Survey and Risk Assessment of Siloxanes in Cosmetic Products.” In Urvey of Chemical Substances in Consumer Products No. 185, edited by L. PB, S. ID, M. TA, D. Rasmussen, A. DN, S. Johannesen. Odense, Denmark: Ministry of Environment of Denmark Environmental Protection Agency. ISBN: 978-87-7038-317-2.
  • Dekant, W., and J. E. Klaunig. 2016. “Toxicology of decamethylcyclopentasiloxane (D5).” Regulatory Toxicology and Pharmacology 74 (Suppl): S67–S76. https://doi.org/10.1016/j.yrtph.2015.06.011.
  • DOW Corning Corporation. 1996a. In vitro Percutaneous Absorption of 14C-Decamethylcyclopentasiloxane (D5) in Rat Skin. Report No: 1995-I0000-41226; Study No. 7659. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 1996b. In vivo Percutaneous Absorption 14C-Decamethylcyclopentasiloxane (D5) in the Rat. Report No: 1996-I0000-41225; Study No: 7660. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 1998. Absorption of 14C-Octamethylcyclotetrasiloxane Using the Flow-Through Diffusion Cell System for in vitro Dermal Absorption in Human Skin. Report No: 1998-I1000–44368; Study No: 8861. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 1999. Non-Regulated Study: Percutaneous Absorption Studies of Octamethylcyclotetrasiloxane (D4) Using the Human Skin/Nude Mouse Model. Authors: Zareba G, Plotzke KP, Utell MJ. Dow Corning Technical Report. 1999-I0000-46491.
  • DOW Corning Corporation. 2000a. Absorption of Hexamethyldisloxane (HMDS) Using the Flow-Through Diffusion Cell System for In Vitro Dermal Absorption in Human Skin. Report No: 2000-I0000-48334. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2000b. In vivo Percutaneous Absorption of 14C- Octamethylcyclotetrasiloxane in the Rat. Report No: 2000-I0000-48335; Study No: 9230. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2000c. Non-regulated study: human dermal absorption of octamethylcyclotetrasiloxane (D4). Report No: 2000-I0000-49147. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2003a. In Vitro Dermal Absorption of 14C-Dodecamethylcyclohexasiloxane (D6) in Human Skin. Report No: 2002-I0000-51728; Study No: 9613. Testing Facility: Midland, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2003b. In Vivo Percutaneous Absorption of 14C-Decamethylcyclopentasiloxane in the Rat. Report No. 2003-I0000–52915; Study No: 9823-101. Testing Facility: Auburn, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2006a. In Vitro Dermal Absorption of 14C-Octamethylcyclotetrasiloxane (14C-D4) Through Swine Skin When Formulated in Three Personal Care Applications. Report No: 2006-CTEC-3119; HES Study Number: 10278-108. Testing Facility: Auburn, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • DOW Corning Corporation. 2006b. In Vitro Percutaneous Penetration of 14C-Decamethyltetrasiloxane (14C-L4) Through Human Skin. Report No: 2006-I0000-56529; Study Number: 10104-102. Testing Facility: Auburn, Michigan. Report Owned by Silicones Environmental, Health and Safety Center (SEHSC).
  • Dudzina, T., E. Garcia Hidalgo, N. von Goetz, C. Bogdal, and K. Hungerbuehler. 2015. “Evaporation of Decamethylcyclopentasiloxane (D5) from Selected Cosmetic Products: Implications for Consumer Exposure Modeling.” Environment International 84:55–63. https://doi.org/10.1016/j.envint.2015.07.013.
  • Dudzina, T., N. von Goetz, C. Bogdal, J. W. Biesterbos, and K. Hungerbühler. 2014. “Concentrations of cyclic volatile methylsiloxanes in European cosmetics and personal care products: prerequisite for human and environmental exposure assessment.” Environment International 62:86–94. https://doi.org/10.1016/j.envint.2013.10.002.
  • ECETOC. 2011. JACC No. 55. Linear Polydimethylsiloxanes. European Centre for Ecotoxicology and Toxicology of Chemicals. CAS No. 63148-62-9 (2nd Ed).
  • ECHA. 2021. Recommendation of the European Chemicals Agency of 14 April 2021 for the Inclusion of Substances in Annex XIV to Reach (List of Substances Subject to Authorisation). Helsinki, Finland: European Chemicals Agency.
  • EFSA. 2015. Dossier – Silicones. The European Food Safety Authority. May. https://doi.org/10.5281/zenodo.33522
  • Franzen, A., T. Greene, C. Van Landingham, and R. Gentry. 2017. “Toxicology of octamethylcyclotetrasiloxane (D4).” Toxicology Letters 279 (Suppl 1): 2–22. https://doi.org/10.1016/j.toxlet.2017.06.007.
  • Gentry, R., A. Franzen, C. Van Landingham, T. Greene, and K. Plotzke. 2017. “A Global Human Health Risk Assessment for Octamethylcyclotetrasiloxane (D4).” Toxicology Letters 279 (Suppl 1): 23–41. https://doi.org/10.1016/j.toxlet.2017.05.019.
  • Goffin, V., C. Letawe, and G. E. Piérard. 1997. “Effect of Organic Solvents on Normal Human Stratum Corneum: Evaluation by the Corneoxenometry Bioassay.” Dermatology 195 (4): 321–324. https://doi.org/10.1159/000245980.
  • GSC. 2023. Personal care and consumer products. Global Silicones Council. https://globalsilicones.org/explore-silicones/benefits-uses/consumer-products/
  • Hobbs, E. J., O. E. Fancher, and J. C. Calandra. 1972. “Effect of Selected Organopolysiloxanes on Male Rat and Rabbit Reproductive Organs.” Toxicology and Applied Pharmacology 21 (1): 45–54. ( As cited in Nair 2003). https://doi.org/10.1016/0041-008x(72)90026-9.
  • Horii, Y., and K. Kannan. 2008. “Survey of Organosilicone Compounds, Including Cyclic and Linear Siloxanes, in Personal-Care and Household Products.” Archives of Environmental Contamination and Toxicology 55 (4): 701–710. https://doi.org/10.1007/s00244-008-9172-z.
  • Huber, P., and W. Kaiser. 1986. “Silicone Fluids: Synthesis, Properties and Applications.” Ournal of Synthetic Lubrication 3 (2): 105–120. https://doi.org/10.1002/jsl.3000030204.
  • Johnson, W., Jr, W. F. Bergfeld, D. V. Belsito, R. A. Hill, C. D. Klaassen, D. C. Liebler, J. G. Marks Jr, et al. 2011. “Safety assessment of cyclomethicone, cyclotetrasiloxane, cyclopentasiloxane, cyclohexasiloxane, and cycloheptasiloxane.” International Journal of Toxicology 30 (6 Suppl): 149S–227S. https://doi.org/10.1177/1091581811428184.
  • Jovanovic, M. L., J. M. McMahon, D. A. McNett, J. M. Tobin, and K. P. Plotzke. 2008. “In vitro and in vivo percutaneous absorption of 14C-octamethylcyclotetrasiloxane (14C-D4) and 14C-decamethylcyclopentasiloxane (14C-D5).” Regulatory Toxicology and Pharmacology 50 (2): 239–248. https://doi.org/10.1016/j.yrtph.2007.11.003.
  • Krenczkowska, D., K. Mojsiewicz-Pieńkowska, B. Wielgomas, D. Bazar, and Z. Jankowski. 2020. “Ex vivo Human Skin is Not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure.” Pharmaceutics 12 (6): 586. https://doi.org/10.3390/pharmaceutics12060586.
  • Krenczkowska, D., K. Mojsiewicz-Pieńkowska, B. Wielgomas, K. Cal, R. Bartoszewski, S. Bartoszewska, and Z. Jankowski. 2019. “The Consequences of Overcoming the Human Skin Barrier by Siloxanes (Silicones) Part 1. Penetration and Permeation Depth Study of Cyclic Methyl Siloxanes.” Chemosphere 231:607–623. https://doi.org/10.1016/j.chemosphere.2018.09.154.
  • Majer, V., J. Sedlbauer, and G. Bergin. 2008. “Henry’s Law Constant and Related Coefficients for Aqueous Hydrocarbons, CO2 and H2S Over a Wide Range of Temperature and Pressure.” Fluid Phase Equilibria 272:65–74. https://doi.org/10.1016/j.fluid.2008.07.013. 1–2
  • Mojsiewicz-Pieńkowska, K., M. Jamrógiewicz, K. Szymkowska, and D. Krenczkowska. 2016. “Direct Human Contact with Siloxanes (Silicones) - Safety or Risk Part 1. Characteristics of Siloxanes (Silicones).” Frontiers in Pharmacology 7:132. https://doi.org/10.3389/fphar.2016.00132.
  • Mojsiewicz-Pieńkowska, K., and D. Krenczkowska. 2018. “Evolution of Consciousness of Exposure to Siloxanes-Review of Publications.” Chemosphere 191:204–217. https://doi.org/10.1016/j.chemosphere.2017.10.045.
  • Mojsiewicz-Pieńkowska, K., E. Stachowska, D. Krenczkowska, D. Bazar, and F. Meijer. 2020. “Evidence of Skin Barrier Damage by Cyclic Siloxanes (Silicones)—Using Digital Holographic Microscopy.” International Journal of Molecular Sciences 21 (17): 6375. https://doi.org/10.3390/ijms21176375.
  • Nair, B., and Cosmetic Ingredients Review Expert Panel. 2003. “Final report on the safety assessment of stearoxy dimethicone, dimethicone, methicone, amino bispropyl dimethicone, aminopropyl dimethicone, amodimethicone, amodimethicone hydroxystearate, behenoxy dimethicone, C24–28 alkyl methicone, C30–45 alkyl methicone, C30–45 alkyl dimethicone, cetearyl methicone, cetyl dimethicone, dimethoxysilyl ethylenediaminopropyl dimethicone, hexyl methicone, hydroxypropyldimethicone, atearamidopropyl dimethicone, stearyl dimethicone, stearyl methicone, and vinyldimethicone.” International Journal of Toxicology 22 (Suppl 2): 11–35.
  • NEA. 2021 “Risk Assessment of VOCs in Handheld Toys for Children.” Norwegian Environment Agency. Report Project No. M-2114|2021
  • NILU. 2020. Survey of Emissions of Volatile Organic Chemicals from Handheld Toys for Children Above 3 Years. Authors: Bohlin-Nizzetto P, Schmidbauer N. Norwegian Institute for Air Research.
  • Plotzke, K. P., M. D. Andriot, and L. A. Naas 2000. Measuring In Vitro Percutaneous Absorption of Two Silicone Oils (350 and 10 cSt) Through Human Female Abdominal and Vaginal Tissue. Unpublished report I0000-49416. Dow Corning, Midland, Michigan, USA. ( As cited in ECETOC 2011).
  • Plotzke, K. P., J. M. McMahon, and B. G. Hubbell 1994. Feasibility study: In vivo percutaneous of 14C-polydimethylsiloxane fluid 350 cSt in the male rats. Unpublished report I0000-38932. Dow Corning, Midland, USA. ( As cited in ECETOC 2011).
  • Plotzke, K. P., M. J. Utell, and J. R. Looney. 2000. “Absorption, Distribution and Elimination of 13C-D4 in Humans After Dermal Administration.” USEPA Document 86010000007. ( As cited in Reddy et al. 2007).
  • Plotzke, K. P., M. J. Utell, and J. R. Looney. 2002. “Absorption, distribution and elimination of 13C-D5 in humans after dermal administration. USEPA document. 84030000008.” ( As cited in Reddy et al. 2007).
  • Danish Environmental Protection Agency. 2022. “Analyses and Risk Assessment of Endocrine Disruptors in Products for Pregnant Women and Children.” In Survey of Chemical Substances in Consumer Products No. 189, edited by Poulsen, P. B., S. Hojriis, B. S. Nielsen, P. B. Larsen, S. Christiansen, R. M. Gelardi, S. Geschke, M. Ostenfeldt, 1–241. Odense, Denmark: Ministry of Environment of Denmark Environmental Protection Agency. ISBN: 978-87-7038-398-1.
  • Reddy, M. B., M. E. Andersen, P. E. Morrow, I. D. Dobrev, S. Varaprath, K. P. Plotzke, and M. J. Utell. 2003. “Physiological Modeling of Inhalation Kinetics of Octamethylcyclotetrasiloxane (D4) in Humans During Rest and Exercise.” Toxicological Sciences 72 (1): 3–18. https://doi.org/10.1093/toxsci/kfg001.
  • Reddy, M. B., R. J. Looney, M. J. Utell, K. P. Plotzke, and M. E. Andersen. 2007. “Modeling of human dermal absorption of octamethylcyclotetrasiloxane (D(4)) and decamethylcyclopentasiloxane (D(5)).” Toxicological Sciences 99 (2): 422–431. https://doi.org/10.1093/toxsci/kfm174.
  • SCCS. 2010. Opinion on Cyclomethicone Octamethylcyclotetrasiloxane (Cyclotetrasiloxane, D4) and Decamethylcyclopentasiloxane (Cyclopentasiloxane, D5). Brussels, Belgium: Scientific Committee on Consumer Safety. SCCS/1241/10
  • Wang, R., R. P. Moody, D. Koniecki, and J. Zhu. 2009. “Low Molecular Weight Cyclic Volatile Methylsiloxanes in Cosmetic Products Sold in Canada: Implication for Dermal Exposure.” Environment International 35:900–904. https://doi.org/10.1016/j.envint.2009.03.009.
  • Xu, S., G. Kozerski, and D. Mackay. 2014. “Critical review and interpretation of environmental data for volatile methylsiloxanes: partition properties.” Environmental Science and Technology 48 (20): 11748–11759. https://doi.org/10.1021/es503465b.
  • Zareba, G., R. Gelein, P. Morrow, and M. Utell. 2002. “Percutaneous Absorption Studies of Octamethylcyclotetrasiloxane Using the Human Skin/Nude Mouse Model.” Skin Pharmacology and Applied Skin Physiology 15 (3): 184–194. https://doi.org/10.1159/000063547.